HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.

Abstract
Classical swine fever (CSF) is among the most important viral disease of domestic and feral pigs and has a serious impact on animal health and pig industry. In most countries with industrialized pig production, prophylactic vaccination against CSF is banned, and all efforts are directed towards eradication of the disease, e.g. by culling of infected herds and animal movement restrictions. Nevertheless, emergency vaccination remains an option to minimize the socio-economic impact of outbreaks. For this application, potent vaccines are needed that allow differentiation of infected from vaccinated animals. Among the promising candidates for next generation marker vaccines is the chimeric pestivirus CP7_E2alf. Efficacy studies are usually carried out using highly virulent CSFV strains of genotype 1 that do not mirror the current field situation where strains of genotype 2 predominate. To prove that CP7_E2alf also protects against these strains, efficacy was assessed after single oral vaccination of wild boar and single intramuscular vaccination of domestic pigs using challenge models with recent CSFV strains and the highly virulent strain "Koslov" (genotype 1.1). It could be demonstrated that CP7_E2alf pilot vaccine batches for intramuscular and oral use were able to protect pigs from challenge infection with a highly virulent CSFV. Moreover, solid protection was also achieved in case of challenge infection with recent field strains of genotypes 2.1 and 2.3. Thus, broad applicability under field conditions can be assumed.
AuthorsSandra Blome, Claudia Gabriel, Stefanie Schmeiser, Denise Meyer, Alexandra Meindl-Böhmer, Frank Koenen, Martin Beer
JournalVeterinary microbiology (Vet Microbiol) Vol. 169 Issue 1-2 Pg. 8-17 (Feb 21 2014) ISSN: 1873-2542 [Electronic] Netherlands
PMID24411658 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Viral
  • Vaccines, Marker
  • Vaccines, Synthetic
  • Viral Vaccines
Topics
  • Administration, Oral
  • Animals
  • Antibodies, Viral (blood)
  • Classical Swine Fever (immunology, prevention & control, virology)
  • Classical Swine Fever Virus (genetics, immunology, isolation & purification, pathogenicity)
  • Genotype
  • Injections, Intramuscular
  • Sus scrofa (immunology)
  • Swine
  • Vaccination (veterinary)
  • Vaccines, Marker (administration & dosage, immunology)
  • Vaccines, Synthetic (administration & dosage, immunology)
  • Viral Vaccines (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: